Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel with Gemcitabine for Relapsed Small Cell Cancer
NCT02769832Phase 2Completed
- Start
- Aug 2016
- Primary completion
- Sep 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in small cell lung cancer (SCLC), Neuroendocrine Neoplasm (NEN). Started Aug 2016; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
small cell lung cancer (SCLC)Neuroendocrine Neoplasm (NEN)
Beyond the preview
Go deeper on NCT02769832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02769832.